CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹142 Cr | ₹192 Cr | ₹344 Cr | ₹236 Cr | ₹223 Cr |
What is the latest Total Current Liabilities ratio of CONCORD BIOTECH ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹142 Cr |
Mar2023 | ₹192 Cr |
Mar2022 | ₹344 Cr |
Mar2021 | ₹236 Cr |
Mar2020 | ₹223 Cr |
How is Total Current Liabilities of CONCORD BIOTECH Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹142 Cr | -25.90 | |
Mar2023 | ₹192 Cr | -44.27 | |
Mar2022 | ₹344 Cr | 45.91 | |
Mar2021 | ₹236 Cr | 5.67 | |
Mar2020 | ₹223 Cr | - |
Compare Total Current Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹19,808.6 Cr | 3.2% | -3.8% | 12.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 3.2% |
-3.8% |
12.9% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses